Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss

Overview of attention for article published in Nature Genetics, February 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 3 news outlets
blogs: 1 blog
twitter: 25 X users

patent: 13 patents
facebook: 3 Facebook pages
f1000: 1 research highlight platform

Readers on

mendeley: 132 Mendeley

So far, Altmetric has seen 27 X posts from 25 X users, with an upper bound of 1,057,220 followers.

predictive biomarker: GWAS defined variations in ACYP2 cisplatin-induced hearing loss #btsm #MDx #ngs (abstract) http://t.co/ya60nLemuM

Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss http://t.co/nrTG5DbS9p

A genomic basis for the toxicity (hearing loss) of cisplatin Rx in childhood #cancer http://t.co/4JsXACMeYa #indivmed http://t.co/FqCnaJWkjt

GWAS study shows variants in ACYP2 gene increase risk of #cisplatin-induced hearing loss in children via @NatureGenet http://t.co/pRLzCoQRnd

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 23 additional X posts.